Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Liver Cancer treatment details. Biologic therapy. The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States

Survival: 11.4 months
Toxicity Grade: 5
Treatments: Biologic therapy
Country: United States
City/State/Province: Houston, TX
Hospital: The University of Texas M. D. Anderson Cancer Center
Journal: Link
Date: 5/2010

This phase II study involved 80 patients with hepatocellular carcinoma, 86.3% of whom were male. The median patient age was 68 years.

Patients were treated with the biologic therapy agent called pegylated arginine deiminase, or ADI-PEG, which is an enzyme that targets an amino acid needed for tumor cell growth.

Treatment-related deaths due to liver failure, gastrointestinal hemorrhage, hepatorenal syndrome, and heart attack were reported. Grade 3 bronchopneumonia was also reported.

The reported median overall survival was 11.4 months.

This study was supported by the Polaris Group, makers of ADI-PEG.

Correspondence: Dr. Steven A. Curley; email:

E-mail to a Friend Email Physician More Information